Financial Instruments (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Summary of Marketable Securities Measured at Fair Value on a Recurring Basis |
The following tables summarize our cash, cash equivalents, and marketable securities measured at fair value on a recurring basis (in millions): | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Total | Cash | | | | | | $ | 15,305 | | Cash equivalents: | | | | | | | Money market funds | | $ | 11,349 | | | $ | 0 | | | $ | 11,349 | | Time deposits | | 0 | | | 3,353 | | | 3,353 | | | Government bonds | | 0 | | | 602 | | | 602 | | | Corporate debt securities | | 0 | | | 99 | | | 99 | | Total cash and cash equivalents | | 11,349 | | | 4,054 | | | 30,708 | | Marketable securities: | | | | | | | Marketable equity securities | | 4,402 | | 1,911 | | 6,313 | Time deposits | | 0 | | | 0 | | | 0 | | | Government bonds | | 0 | | 50,549 | | 50,549 | | Corporate debt securities | | 0 | | 21,565 | | 21,565 | | Mortgage-backed and asset-backed securities | | 0 | | 17,708 | | 17,708 | Total marketable securities | | 4,402 | | | 91,733 | | | 96,135 | | | Total | | $ | 15,751 | | | $ | 95,787 | | | $ | 126,843 | |
| | | | | | | | | | | | | | | | | | | | | | | As of March 31, 2026 | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Total | Cash | | | | | | $ | 15,408 | | Cash equivalents: | | | | | | | | Money market funds | | $ | 16,686 | | | $ | 0 | | | $ | 16,686 | | | Time deposits | | 0 | | | 2,966 | | | 2,966 | | | Government bonds | | 0 | | | 2,946 | | | 2,946 | | | Corporate debt securities | | 0 | | | 57 | | | 57 | | Total cash and cash equivalents | | 16,686 | | | 5,969 | | | 38,063 | | Marketable securities: | | | | | | | Marketable equity securities | | 5,541 | | 503 | | 6,044 | | Time deposits | | 0 | | | 0 | | | 0 | | | Government bonds | | 0 | | 43,204 | | 43,204 | | Corporate debt securities | | 0 | | 21,763 | | 21,763 | | Mortgage-backed and asset-backed securities | | 0 | | 17,766 | | 17,766 | Total marketable securities | | 5,541 | | | 83,236 | | | 88,777 | | | Total | | $ | 22,227 | | | $ | 89,205 | | | $ | 126,840 | |
|
| Schedule of Investments by Maturity Date |
The following table summarizes the estimated fair value of investments in available-for-sale marketable debt securities by effective contractual maturity dates (in millions): | | | | | | | As of March 31, 2026 | | Due in 1 year or less | $ | 14,323 | | | Due in 1 year through 5 years | 42,670 | | | Due in 5 years through 10 years | 12,471 | | | Due after 10 years | 13,269 | | | Total | $ | 82,733 | |
|
| Schedule of Available-for-Sale Debt Securities |
The following tables present fair values and gross unrealized gains and losses recorded to accumulated other comprehensive income (AOCI), less any expected credit losses, aggregated by investment category (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | Adjusted Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Time deposits | | $ | 3,353 | | | $ | 0 | | | $ | 0 | | | $ | 3,353 | | | Government bonds | | 49,087 | | 443 | | | (26) | | | 49,504 | | | Corporate debt securities | | 18,346 | | | 242 | | | (32) | | | 18,556 | | | Mortgage-backed and asset-backed securities | | 14,337 | | | 174 | | | (128) | | | 14,383 | | Total investments with fair value change reflected in other comprehensive income | | $ | 85,123 | | | $ | 859 | | | $ | (186) | | | $ | 85,796 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of March 31, 2026 | | | Adjusted Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Time deposits | | $ | 2,966 | | | $ | 0 | | | $ | 0 | | | $ | 2,966 | | | Government bonds | | 44,465 | | 272 | | | (101) | | | 44,636 | | | Corporate debt securities | | 18,737 | | | 124 | | | (63) | | | 18,798 | | | Mortgage-backed and asset-backed securities | | 14,627 | | | 109 | | | (160) | | | 14,576 | | Total investments with fair value change reflected in other comprehensive income | | $ | 80,795 | | | $ | 505 | | | $ | (324) | | | $ | 80,976 | |
|
| Schedule of Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value |
The following tables present fair values and gross unrealized losses recorded to AOCI, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | Less than 12 Months | | 12 Months or Greater | | Total | | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Government bonds | $ | 4,230 | | | $ | (9) | | | $ | 1,174 | | | $ | (17) | | | $ | 5,404 | | | $ | (26) | | | Corporate debt securities | 915 | | | 0 | | | 2,429 | | | (24) | | | 3,344 | | | (24) | | | Mortgage-backed and asset-backed securities | 1,377 | | | (4) | | | 3,035 | | | (124) | | | 4,412 | | | (128) | | | Total | $ | 6,522 | | | $ | (13) | | | $ | 6,638 | | | $ | (165) | | | $ | 13,160 | | | $ | (178) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of March 31, 2026 | | | Less than 12 Months | | 12 Months or Greater | | Total | | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Government bonds | $ | 14,349 | | | $ | (85) | | | $ | 890 | | | $ | (16) | | | $ | 15,239 | | | $ | (101) | | | Corporate debt securities | 5,506 | | | (17) | | | 1,826 | | | (19) | | | 7,332 | | | (36) | | | Mortgage-backed and asset-backed securities | 5,228 | | | (40) | | | 1,972 | | | (120) | | | 7,200 | | | (160) | | | Total | $ | 25,083 | | | $ | (142) | | | $ | 4,688 | | | $ | (155) | | | $ | 29,771 | | | $ | (297) | |
|
| Schedule of Gains and Losses on Equity Securities |
The following table summarizes gains and losses for debt securities, reflected as a component of OI&E (in millions): | | | | | | | | | | | | | | | | | Three Months Ended | | | | March 31, | | | | | 2025 | | 2026 | | | | | | Unrealized gain (loss) on fair value option debt securities | $ | 97 | | | $ | (142) | | | | | | | Gross realized gain on debt securities | 266 | | | 83 | | | | | | | Gross realized loss on debt securities | (175) | | | (33) | | | | | | | (Increase) decrease in allowance for credit losses | 14 | | | (19) | | | | | | | Total gain (loss) on debt securities recognized in other income (expense), net | $ | 202 | | | $ | (111) | | | | | |
Gains and losses (including impairments), net, for equity securities included in OI&E are summarized below (in millions): | | | | | | | | | | | | | | | | | Three Months Ended | | | | March 31, | | | | 2025 | | 2026 | | | | | Gross unrealized gain on non-marketable equity securities accounted for under the measurement alternative | $ | 9,715 | | | $ | 36,660 | | | | | | Gross unrealized loss (including impairments) on non-marketable equity securities accounted for under the measurement alternative | (399) | | | (346) | | | | | | Unrealized net gain (loss) on non-marketable equity securities accounted for under the measurement alternative | 9,316 | | | 36,314 | | | | | | Unrealized net gain (loss) on marketable and other equity securities | 227 | | | 105 | | | | | | Realized net gain (loss) on marketable and non-marketable equity securities sold during the period | 215 | | | 496 | | | | | | Total gain (loss) on equity securities in other income (expense), net (1) | $ | 9,758 | | | $ | 36,915 | | | | | |
(1)Excludes income (loss) and impairment from equity method investments. Refer to Note 7 for further details.
|
| Schedule of Non-Marketable Securities |
The carrying values for non-marketable securities are summarized below (in millions): | | | | | | | | | | | | | | | As of December 31, 2025 | | As of March 31, 2026 | Non-marketable securities: | | | | | Total initial cost of non-marketable equity securities accounted for under the measurement alternative | | $ | 28,429 | | | $ | 29,489 | | Cumulative upward adjustments | | 44,485 | | | 80,792 | | Cumulative downward adjustments (including impairments) | | (8,820) | | | (8,935) | | Carrying value of non-marketable equity securities accounted for under the measurement alternative | | 64,094 | | | 101,346 | | Equity method investments and other | | 4,593 | | | 5,600 | | Total non-marketable securities | | $ | 68,687 | | | $ | 106,946 | |
|
| Schedule of Gross Notional Amounts of Derivative Instruments |
The gross notional amounts of outstanding derivative instruments were as follows (in millions): | | | | | | | | | | | | | As of December 31, 2025 | | As of March 31, 2026 | Derivatives designated as hedging instruments: | | | | Foreign exchange derivatives | | | | | Cash flow hedges | $ | 23,852 | | | $ | 23,448 | | | Net investment hedges | $ | 14,203 | | | $ | 14,020 | | | Derivatives not designated as hedging instruments: | | | Foreign exchange derivatives | $ | 56,085 | | | $ | 51,976 | | Equity derivatives | $ | 0 | | | $ | 30,000 | | Credit derivatives | $ | 16,940 | | | $ | 28,436 | | | Other derivatives | $ | 15,900 | | | $ | 15,862 | |
|
| Schedule of Derivative Instruments |
The fair values of outstanding derivative instruments were as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | As of March 31, 2026 | | Assets(1) | | Liabilities(2) | | Assets(1) | | Liabilities(2) | | Derivatives designated as hedging instruments: | | | | | | | | Foreign exchange derivatives | $ | 316 | | | $ | 197 | | | $ | 991 | | | $ | 39 | | | | | | | | | | | Derivatives not designated as hedging instruments: | | | | | | | | Foreign exchange derivatives | 92 | | 15 | | 244 | | 472 | Credit derivatives | 0 | | 69 | | 0 | | 339 | Other derivatives | 324 | | 98 | | 375 | | 40 | | Total derivatives not designated as hedging instruments | 416 | | | 182 | | | 619 | | | 851 | | | Total | $ | 732 | | | $ | 379 | | | $ | 1,610 | | | $ | 890 | |
(1) Derivative assets are recorded as other current and non-current assets. (2) Derivative liabilities are recorded as accrued expenses and other liabilities, current and non-current.
|
| Schedule of Gain (Loss) on Derivative Instruments |
The gains (losses) on derivatives and non-derivative financial instruments in cash flow hedging and net investment hedging relationships recognized in other comprehensive income are summarized below (in millions): | | | | | | | | | | | | | | | | | Three Months Ended | | | | | March 31, | | | | 2025 | | 2026 | | | | | Cash flow hedging relationship: | | | | | | | | Foreign exchange and other derivatives | | | | | | | | | Amount included in the assessment of effectiveness | $ | (339) | | | $ | 259 | | | | | | | Amount excluded from the assessment of effectiveness | (61) | | | 83 | | | | | | | | | | | | | | Net investment hedging relationship: | | | | | | | | Amount included in the assessment of effectiveness | | | | | | | | | Foreign exchange derivatives | (206) | | | 320 | | | | | | | Foreign currency-denominated debt | 0 | | | 440 | | | | | | Amounts excluded from the assessment of effectiveness | | | | | | | | | Foreign exchange derivatives | 0 | | | 1 | | | | | | | Total | $ | (606) | | | $ | 1,103 | | | | | |
The table below presents the gains (losses) of derivatives included in the Consolidated Statements of Income: (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | 2025 | | 2026 | | Revenues | | Other income (expense), net | | Revenues | | Other income (expense), net | | Total amounts included in the Consolidated Statements of Income | $ | 90,234 | | | $ | 11,183 | | | $ | 109,896 | | | $ | 37,716 | | | | | | | | | | | Effect of cash flow hedges: | | | | | | | | | Foreign exchange derivatives | | | | | | | | Amount included in the assessment of effectiveness | $ | 242 | | | $ | 0 | | | $ | (211) | | | $ | 0 | | Amount excluded from the assessment of effectiveness | 18 | | | 0 | | | 31 | | | 0 | | | Effect of fair value hedges: | | | | | | | | | Foreign exchange derivatives | | | | | | | | | Hedged items | 0 | | | (9) | | | 0 | | | 0 | | Amount included in the assessment of effectiveness | 0 | | | 9 | | | 0 | | | 0 | | | Amount excluded from the assessment of effectiveness | 0 | | | 1 | | | 0 | | | 0 | | | Effect of net investment hedges: | | | | | | | | | Foreign exchange derivatives | | | | | | | | | Amount excluded from the assessment of effectiveness | 0 | | | 31 | | | 0 | | | 62 | | | Effect of non-designated hedges: | | | | | | | | | Foreign exchange derivatives | 0 | | | 65 | | | 0 | | | (179) | | | Credit derivatives | 0 | | | 0 | | | 0 | | | (148) | | | Other derivatives | 0 | | | (71) | | | 0 | | | 14 | | | Total gains (losses) | $ | 260 | | | $ | 26 | | | $ | (180) | | | $ | (251) | |
|
| Schedule of Offsetting Assets |
The gross amounts of derivative instruments subject to master netting arrangements with various counterparties, and cash and non-cash collateral received and pledged under such agreements were as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | Gross Amounts Recognized | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Amounts Presented in the Consolidated Balance Sheets | | Financial Instruments(1) | | Cash and Non-Cash Collateral Received or Pledged | | Net Amounts | | Derivatives assets | $ | 842 | | | $ | (110) | | | $ | 732 | | | $ | (140) | | | $ | (231) | | | $ | 361 | | | Derivatives liabilities | $ | 489 | | | $ | (110) | | | $ | 379 | | | $ | (140) | | | $ | (15) | | | $ | 224 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of March 31, 2026 | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | Gross Amounts Recognized | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Amounts Presented in the Consolidated Balance Sheets | | Financial Instruments(1) | | Cash and Non-Cash Collateral Received or Pledged | | Net Amounts | Derivatives assets(1) | $ | 1,725 | | | $ | (115) | | | $ | 1,610 | | | $ | (470) | | | $ | (696) | | | $ | 444 | | | Derivatives liabilities | $ | 1,005 | | | $ | (115) | | | $ | 890 | | | $ | (470) | | | $ | (18) | | | $ | 402 | |
(1)The balances as of December 31, 2025 and March 31, 2026 were related to derivatives allowed to be net settled in accordance with our master netting agreements.
|
| Schedule of Offsetting Liabilities |
The gross amounts of derivative instruments subject to master netting arrangements with various counterparties, and cash and non-cash collateral received and pledged under such agreements were as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | Gross Amounts Recognized | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Amounts Presented in the Consolidated Balance Sheets | | Financial Instruments(1) | | Cash and Non-Cash Collateral Received or Pledged | | Net Amounts | | Derivatives assets | $ | 842 | | | $ | (110) | | | $ | 732 | | | $ | (140) | | | $ | (231) | | | $ | 361 | | | Derivatives liabilities | $ | 489 | | | $ | (110) | | | $ | 379 | | | $ | (140) | | | $ | (15) | | | $ | 224 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of March 31, 2026 | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | Gross Amounts Recognized | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Amounts Presented in the Consolidated Balance Sheets | | Financial Instruments(1) | | Cash and Non-Cash Collateral Received or Pledged | | Net Amounts | Derivatives assets(1) | $ | 1,725 | | | $ | (115) | | | $ | 1,610 | | | $ | (470) | | | $ | (696) | | | $ | 444 | | | Derivatives liabilities | $ | 1,005 | | | $ | (115) | | | $ | 890 | | | $ | (470) | | | $ | (18) | | | $ | 402 | |
(1)The balances as of December 31, 2025 and March 31, 2026 were related to derivatives allowed to be net settled in accordance with our master netting agreements.
|